Skip to content
NASDAQ · PHARMACEUTICAL PREPARATIONS · SMALL CAP

Mustang Bio, Inc. MBIO

10 fiscal years on record · USD · FY2025 reported · SEC filings only
$-1.9M

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Growth

·
Revenue, FY2025 · full 10-year series below
Revenue $M Net income $M
FY2019 · Revenue 0.0 · Net income -46.4
-20M-40M
2016201920222025
Compound annual growth
3 yrs
5 yrs
10 yrs
15 yrs

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

·
ROE
FY2023 · ROE -222.4%
-100%-200%
201620202025
Three returns, three denominators.
Return on equityNot applicable: equity was zero or negative in this period, so return on equity has no meaning.
Return on capital employedNot applicable: capital employed was zero or negative in this period, so return on capital employed has no meaning.

Cash & shareholders

·
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2024 · FCF -11.4
-25.0M-50.0M
201620202025

Total assetsUSD 17.6M
EquityUSD 9.5M
CashUSD 17.3M
Current ratio2.22×

Equity funds 54% of total assets.

The 10-year record

10 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative—not applicable◌not available in our data
MBIO, 10-year financial record
Metric 2025202420232022202120202019201820172016
Revenue $B◌◌◌◌◌◌0.0◌0.00.0
Operating income $B−0.0−0.0−0.0−0.1−0.1−0.1−0.0−0.0−0.0−0.0
EBITDA $B−0.0−0.0−0.0−0.1−0.1−0.1−0.0−0.0−0.0−0.0
Income tax $B0.0◌◌◌◌◌◌◌◌◌
Net income $B−0.0−0.0−0.1−0.1−0.1−0.1−0.0−0.0−0.0−0.0
Free cash flow $B◌−0.0−0.0−0.1−0.1−0.0−0.0−0.0−0.0◌
EPS, diluted $−0.39−38.57−299.95−10.09−0.76−1.14−1.29−1.14−1.24−1.15
Dividend / sh $◌◌◌◌◌◌◌◌◌◌
Payout % — not applicable: no dividend——————————
ROE %——−222.4−97.7−63.0−80.0−105.4−63.7−74.4—
Shares out B◌◌◌◌◌0.070.000.000.030.02

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

Provenance

Company facts, as filed

How we verify · 1 failure in 43 reconciliationsAUDITED

Reconciled in 9 of the 10 fiscal years we could check. 16 checks were skipped: the balance sheet is not tagged before 2015. Nine checks were skipped: EPS is not tagged before 2016.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency1 failure
ActivityPharmaceutical Preparations
Listed onNASDAQ
Incorporated inDelaware
Fiscal year endsDecember 31
SEC categorysmaller reporting company
Data on record since2015

Share this section

Download image